Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2018

View Archived Issues

Predicting chemotherapy synergies

Repair cells can make things worse in neuromuscular disease

New arthritis severity gene id'd

Mortalin Kombat: Lysosomal inhibitor findings have cancer therapy implications

Award for Logic Biosciences' LBS-101 for oral mucositis

Mouse model reveals role of amylin signaling in POMC neurons in food intake, energy metabolism

Circadian regulation through MTNR1A contributes to the pathological cascade of Alzheimer's disease

SliC, a lysozyme-binding lipoprotein of N. gonorrhoeae with a key role during host colonization

Gut microbiota-derived metabolite TMAO found elevated in patients with Alzheimer's disease

ABL Bio and I-Mab enter immuno-oncology partnering agreement

Rxulti approved in E.U. for schizophrenia

European Commission approves Pfizer trastuzumab biosimilar Trazimera

Purdue completes phase Ib study of small molecule for insomnia associated with alcohol cessation

Myalepta approved for lipodystrophy in E.U.

Asterias releases Cohort 3 and 4 data from phase I/IIa SCiStar trial in severe spinal cord injury

European Commission approves Xeljanz for ulcerative colitis

Neuralstem begins phase II study of NSI-566 for ischemic stroke

NeuroActiva presents phase I data for NA-831 for Alzheimer's disease

New kinase inhibitors developed at IMPACT Therapeutics

Enanta Pharmaceuticals identifies respiratory syncytial virus inhibitors

ViiV Healthcare UK patents HIV integrase inhibitors

TGF-beta receptor type-1/2 inhibitors discovered at Bristol-Myers Squibb

Renji Hospital synthesizes aaptamine alkaloid derivatives

New phase I trial explores use of CERC-301 for neurogenic orthostatic hypotension in Parkinson's

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...